文献速递主动脉疾病

Treovance覆膜支架治疗腹主动脉瘤早期结果

Early Results of the Bolton Treovance Endograft in the Treatment of Abdominal Aortic Aneurysms.
PubMed 文献 · J Endovasc Ther · 2017-06-09

该研究评估Treovance主动脉覆膜支架治疗腹主动脉瘤的早期效果,纳入35例连续患者(平均年龄74±7.7岁,32例男性),主要终点为内漏、再干预和动脉瘤相关死亡。随访平均12个月,临床成功率97%,无I/III型内漏或动脉瘤破裂,再干预率3%;支架在成角和迂曲髂血管中释放准确,对高度成角瘤颈顺应性满意。

要点

  • Treovance支架治疗腹主动脉瘤早期临床成功率97%,无动脉瘤破裂或开放转换。
  • 术中2例Ia型内漏经近端主动脉延伸成功治疗,辅助技术成功率100%。
  • 平均12个月随访无I/III型内漏,再干预率3%(1例II型内漏相关瘤囊增大)。

核心结论

  • Treovance支架在成角和迂曲髂血管中释放准确,对高度成角瘤颈顺应性满意,临床结果可接受。

研究设计与样本

  • 单中心前瞻性观察研究,2013年10月至2016年1月连续纳入35例腹主动脉瘤患者,平均年龄74±7.7岁,32例男性。
  • 治疗动脉瘤最大直径60±9 cm(原文单位),9例(25%)合并髂动脉瘤,7例(20%)肾下瘤颈成角>60°。
  • 肾下瘤颈长度和直径分别为21.6±12.6 mm和25.7±4.6 mm,16例(45%)瘤颈呈倒锥形。
  • 6例(17%)和9例(25%)患者分别存在重度或中度髂动脉迂曲。

主要发现

  • 主要技术成功率94%,因2例术中Ia型内漏经近端主动脉延伸成功治疗,辅助主要技术成功率100%。
  • 4例患者共5个(7%)股动脉入路部位发生局部夹层(共70个入路部位)。
  • 平均12个月随访(范围6-24个月)临床成功率97%,无I/III型内漏、死亡、动脉瘤破裂、开放转换或器械相关严重不良事件。
  • 检出4例II型内漏,1例12个月时自愈,2例稳定,1例伴瘤囊增大经腰动脉栓塞成功治疗(再干预率3%)。

临床怎么用

  • 对于瘤颈成角>60°或髂动脉迂曲的腹主动脉瘤患者,Treovance支架可作为治疗选择,释放准确且顺应性满意。
  • 术后需监测II型内漏及瘤囊变化,必要时行栓塞干预。
  • 未来需降低输送系统Profile并增加柔顺性,以改善狭窄入路血管的适用性。

局限性

  • 样本量小(35例),随访时间短(平均12个月,范围6-24个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To present early results with the Treovance aortic stent-graft in the treatment of abdominal aortic aneurysms (AAAs). METHODS: Between October 2013 and January 2016, 35 consecutive AAA patients (mean age 74±7.7 years; 32 men) were treated with Treovance. The maximum diameter of the treated AAA was 60±9 cm. Nine (25%) patients presented with concomitant iliac aneurysms. Seven (20%) AAAs had infrarenal neck angulation >60°. The infrarenal neck length and diameter were 21.6±12.6 mm and 25.7±4.6 mm, respectively. Sixteen (45%) AAAs had a reversed tapered neck contour. Six (17%) and 9 (25%) patients showed severe or moderate iliac tortuosity, respectively. Primary endpoints were endoleak, reintervention, and aneurysm-related death. RESULTS: Primary technical success was 94% due to 2 intraoperative type Ia endoleaks, which were successfully treated with a proximal aortic extension (100% assisted primary technical success). Local dissection was encountered in 5 (7%) of 70 femoral artery access sites in 4 patients. During a mean 12-month follow-up (range 6-24), clinical success was 97%. No type I or III endoleak, death, AAA rupture, open conversion, or device-related serious adverse events were documented. Four type II endoleaks were detected; one resolved spontaneously at 12 months and 2 remained stable, while one associated with AAA sac enlargement was treated successfully with embolization of the lumbar arteries (3% reintervention rate). CONCLUSION: Treovance shows accurate deployment even through angulated and tortuous iliac vessels and presents satisfactory conformability in highly angulated necks with acceptable clinical results. Future development to lower the profile and increase the flexibility of its delivery system will enhance its applicability in cases of narrow access vessels.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Georgakarakos E, Pitoulias G, Schoretsanitis N, et al. Early Results of the Bolton Treovance Endograft in the Treatment of Abdominal Aortic Aneurysms. J Endovasc Ther. 2017. PMID: 28597730. doi:10.1177/1526602817713736

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。